A scientific and clinical authority on obesity research, treatment, and policy, bringing together researchers, clinicians, and advocates.
Updated Jul 14, 2026
researchclinicalprofessional-organizationofficial
Was this helpful?
Improve this page▾
Related terms
Obesity Action Coalition (OAC) — A U.S. nonprofit patient advocacy organization focused on obesity education, awareness, and access to treatment.
Related guides
Obesity Action Coalition (official site) — The national patient advocacy nonprofit's official site — education, community support, and advocacy resources for people affected by obesity.
FDA's proposal to keep compounded GLP-1s off the 503B bulks list — and how to comment — In May 2026 the FDA proposed to exclude semaglutide, tirzepatide, and liraglutide from the 503B compounding bulks list — a decision that affects how compounded GLP-1s can be made. The public comment period is open (as reported, through July 30, 2026). Here's what the proposal is, why it matters for access, and how to submit a comment.
What to say when your employer's benefits team says no — A "no" from HR or benefits isn't always final — it often just means the current plan year's decision has been made. Here's how to respond productively and keep the door open for next year.